The Clover Corporation Board of Directors and Management team brings a wealth of experience to the company, helping achieve our vision to optimise the health and development of infants and children.
BOARD OF DIRECTORS The Clover Corporation Board of Directors comprises our non-executive Chairman, our CEO and Managing Director and three non-executive Directors.
Chairman Non-executive director
Peter Robinson has over 30 years experience at general management and chief executive level and has held both executive and non-executive directorships at Clover for over 24 years.
He joined Washington H Soul Pattinson and Company Limited (WHSP) in 1978 and was appointed an executive director in 1984. He is also the non-executive Chairman of Australian Pharmaceutical Industry Limited, and the non-executive director of New Hope Corporation Limited.
Peter has been a Non-executive Director of Clover Corporation since 1997 and was appointed Chairman of Clover Corporation Limited on 1 December 2002.
Other current company directorships held:
- Australian Pharmaceutical Industries Limited, appointed 2000, current.
- New Hope Corporation Limited, appointed 2000, current.
- WHSP, appointed 1984, current.
Previous company directorships:
- Northern Energy Corporation Limited – Appointed 2011 (company delisted October 2011).
- Exco Resources Limited appointed 2012 (company delisted 2013).
Non-executive Director. Member of the audit and remuneration committees.Chair of nominations committee.
Non-executive Director. Member of the audit and remuneration committees.Chairperson of the remuneration committees. Chairperson of the remuneration committee.
Non-executive director. Chairman of the audit committee. Member of the remuneration committee.
Managing Director & CEO
Chief Financial Officer
Research, Quality & Regulatory Manager
Human Resource and Payroll Manager